Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Bioventus (BVS) Leases (2020 - 2025)

Bioventus' Leases history spans 6 years, with the latest figure at $15.7 million for Q4 2025.

  • For Q4 2025, Leases changed 0.11% year-over-year to $15.7 million; the TTM value through Dec 2025 reached $15.7 million, changed 0.11%, while the annual FY2025 figure was $15.7 million, 0.11% changed from the prior year.
  • Leases reached $15.7 million in Q4 2025 per BVS's latest filing, up from $11.6 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $18.7 million in Q2 2022 to a low of $6.6 million in Q1 2025.
  • Average Leases over 5 years is $15.3 million, with a median of $15.7 million recorded in 2024.
  • Peak YoY movement for Leases: rose 14.87% in 2021, then plummeted 52.24% in 2025.
  • A 5-year view of Leases shows it stood at $17.2 million in 2021, then decreased by 2.89% to $16.7 million in 2022, then dropped by 14.45% to $14.3 million in 2023, then increased by 10.21% to $15.7 million in 2024, then decreased by 0.11% to $15.7 million in 2025.
  • Per Business Quant, the three most recent readings for BVS's Leases are $15.7 million (Q4 2025), $11.6 million (Q3 2025), and $12.0 million (Q2 2025).